市场调查报告书
商品编码
1320987
尿路感染检测市场-按测试类型(尿液分析、尿培养、药敏测试)、按测试套件类型(实验室测试套件、家庭测试套件)、按应用(尿道炎、膀胱炎、肾盂肾炎)、按最终用途和预测, 2023-2032Urinary Tract Infection Testing Market-By Test Type (Urinalysis, Urine Cultures, Susceptibility Testing), By Test Kit Type (Laboratory Test Kits, Home Test Kits), By Application (Urethritis, Cystitis, Pyelonephritis), By End-use & Forecast, 2023-2032 |
到 2032 年,全球尿路感染检测市场规模将大幅扩大。有利的报销政策、促进医疗基础设施发展的政府倡议以及不断增长的老年人口推动了尿路感染检测市场的发展。例如,美国卫生与公众服务部 (HHS) 发起了尿路感染预防和控制 (UTI-PCC) 倡议。该计划的重点是提高人们对尿路感染的认识,并为医疗保健提供者和患者提供资源。
由于对有效诊断解决方案的需求不断增加以及尿路感染髮病率上升(主要是女性和老年人),市场将会扩大。人们越来越意识到未经治疗的尿路感染的潜在并发症以及对早期准确检测方法的需求推动了市场的发展。此外,从长远来看,分子诊断和自动尿液分析仪等诊断技术的技术进步将增强市场潜力。
整个尿路感染检测市场根据测试类型、应用、最终用户和地区进行分类。
就测试类型而言,到 2032 年,尿液分析领域将占据一定的市场份额。尿液分析是用于检测和诊断尿路感染的常见且重要的诊断工具。它涉及对尿液样本进行分析,以确定是否存在细菌、白细胞和其他感染指标。全球尿路感染髮病率的不断上升将推动对尿液分析的需求,将其作为支持其增强的主要测试方法。因此,尿路感染检测市场对尿液分析的需求仍然很高。
根据该应用,尿道炎细分市场将在 2022 年至 2023 年间呈现巨大增长。人们对未经治疗的尿道炎并发症的认识不断提高,以及性传播感染髮病率的上升,增加了专门针对尿道炎的尿路感染检测的需求。尿路感染检测方法,如尿培养、分子诊断和快速抗原检测,用于识别引起尿道炎的病原体的存在,从而导致了更多的需求。因此,采用率的不断提高将支持尿道炎领域。
根据最终用途,诊断实验室在预测期内将以惊人的增长率增长。这些实验室在准确、及时诊断尿路感染方面发挥着至关重要的作用,并有助于预防尿路感染。人们越来越认识到早期尿路感染检测的重要性,并且尿路感染病例数量不断增加,推动了诊断实验室对尿路感染检测的需求。此外,医疗保健提供者依靠诊断实验室来进行各种测试,包括尿培养、尿液分析和分子诊断。因此,UTI 测试市场受益于这些设施产生的持续需求。
从地区来看,由于亚太地区尿路感染的患病率不断上升,亚太地区尿路感染检测市场可能会积累可观的市场份额。政府改善医疗基础设施的倡议和不断增加的医疗支出进一步推动了亚太地区尿路感染检测市场的发展。此外,主要市场参与者的存在和创新诊断解决方案的采用有助于该地区的行业增长。
Global Urinary Tract Infection Testing Market size will expand significantly through 2032. Favorable reimbursement policies, government initiatives promoting healthcare infrastructure development, and the rising geriatric population boost the UTI testing market. For instance, the U.S. Department of Health and Human Services (HHS) launched the Urinary Tract Infection Prevention and Control (UTI-PCC) initiative. The initiative focuses on raising awareness of UTIs and providing resources to healthcare providers and patients.
The market will expand due to the increasing need for effective diagnostic solutions and the rising incidence of UTIs, primarily among women and aging people. The growing awareness about the potential complications of untreated UTIs and a need for early and accurate testing methods drives the market. Additionally, technological advancements in diagnostic techniques, such as molecular diagnostics and automated urine analyzers, will boost market potential in the long run.
The overall Urinary Tract Infection Testing Market is classified based on test type, application, end-user, and region.
Regarding the test type, the urinalysis segment will capture a modest market share by 2032. Urinalysis is a common and essential diagnostic tool used to detect and diagnose UTIs. It involves the analysis of urine samples to identify the presence of bacteria, white blood cells, and other indicators of infection. The increasing incidence of UTIs globally will push the demand for urinalysis as a primary testing method supporting its augmentation. Consequently, the demand for urinalysis in the UTI testing market remains high.
Based on the application, the urethritis segment will exhibit tremendous growth between 2022-2023. The increasing awareness about the complications of untreated urethritis and the rising incidence of sexually transmitted infections contribute to the demand for UTI testing specifically targeting urethritis. UTI testing methods, such as urine culture, molecular diagnostics, and rapid antigen tests, are utilized to identify the presence of pathogens causing urethritis, leading to more demand. Therefore, the increasing rate of adoption will support the urethritis segment.
Based on the end-use, diagnostic laboratories will rise with an admirable growth rate during the forecast period. These laboratories play a vital role in accurate and timely diagnosis of UTIs and can help prevent them. The increasing awareness about the importance of early UTI detection and the growing volume of UTI cases drive the demand for UTI testing in diagnostic laboratories. Additionally, Healthcare providers rely on diagnostic laboratories to perform various tests, including urine cultures, urinalysis, and molecular diagnostics. As a result, the UTI Testing Market benefits from the continuous demand generated by these facilities.
Regionally, APAC urinary tract infection testing market could accumulate a substantial market share due to the growing prevalence of UTIs in the Asia Pacific region. The government initiatives to improve healthcare infrastructure and the increasing healthcare expenditure further propel the UTI testing market in APAC. Moreover, the presence of major market players and the adoption of innovative diagnostic solutions contribute to industry growth in the region.